Demant
ESRS disclosure: ESRS S4 \ DR S4-1 \ Paragraph AR 9
Tags Tree
- Can the company provide a detailed account of the process used to establish targets related to managing material negative impacts, advancing positive impacts, and managing material risks and opportunities, as outlined in Disclosure Requirement S4-5? This should include whether and how the company engaged directly with consumers, end-users, their legitimate representatives, or credible proxies with insight into their situation. Additionally, in accordance with Disclosure Requirement S4-1, the company is required to describe the key information necessary to ensure a faithful representation of the policies concerning consumers and end-users. This description must include explanations of any significant changes to the policies adopted during the reporting year, such as new expectations for business customers or new approaches to due diligence and remedy.
-
Question Id: S4-1_08
In 2024, Demant established new targets for advancing positive impacts on people with hearing loss: Improve more than 16 million lives by 2030, Increase awareness by performing hearing tests on more than 2 million people by 2030. The targets are set in relation to the overall ambition and purpose of Demant. The targets cover all markets where Demant is present. The target-setting process involved internal experts and was approved by Demant’s Executive Leadership Team and endorsed by the Board of Directors. Consumers and end-users were not directly involved in the process.
Report Date: 4Q2024Relevance: 60%
- Provide a detailed account of the methods employed to track and assess the effectiveness of actions and initiatives aimed at delivering intended outcomes for consumers and end-users, in accordance with Disclosure Requirement S4-4 concerning material impacts on consumers and end-users, as well as the management of related risks and opportunities.
-
Question Id: S4-4_04
Demant monitors the quality of its products and uses both external audits and complaints mechanisms to assess the effectiveness of actions. All development and manufacturing sites are audited on an ongoing basis in accordance with certification requirements. In 2024, audits in the Hearing Aids business area resulted in minor non-conformances, which were reviewed and closed by authorities. No major findings were reported in the Diagnostics business area.
Report Date: 4Q2024Relevance: 80%